The recent announcement that New Jersey-based healthcare equipment company Becton, Dickinson & Corp. will be acquiring San Diego-based medical products firm CareFusion Corp. in a transaction valued by S&P Capital IQ at $14.2 billion marks a continuation of an already month and year for healthcare M&A activity.
In the last thirty days nearly 100 M&A deals have taken place in the US healthcare sector with a total value of nearly $32 billion. Aside from the recently announced CareFusion deal, last week saw Johnson & Johnson purchase privately-held Ailos BioPharma for $1.75 billion and AMAG Pharmaceuticals Inc. agreed to acquire Lumara Health Inc. for $1.02 billion.
Other notable healthcare deals of late include Endo International plc making a proposal to acquire Auxilium Pharmaceuticals Inc. for $1.4 billion in cash and stock on September 12 and Cognizant Technology Solutions Corporation entering into a stock purchase agreement to acquire TriZetto Corporation for $2.7 billion in cash on September 14.
To date, over $225 billion in US healthcare M&A transactions have been announced compared to less $90 billion in deals a year ago at this time.